Pnc Financial Services Group, Inc. Regenxbio Inc. Transaction History

Pnc Financial Services Group, Inc.

$148 Billion
Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 111 shares of RGNX stock, worth $943. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111

Previous 4,067 97.27%

Holding current value

$943

Previous $42,000 100.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$7.23 - $11.56 $28,601 - $45,731	-3,956 Reduced 97.27%	111 $0
Q3 2024 Nov 08, 2024	BUY	$10.49 - $14.39 $28,469 - $39,054	2,714 Added 200.59%	4,067 $42,000
Q2 2024 Aug 09, 2024	SELL	$11.51 - $21.53 $6,595 - $12,336	-573 Reduced 29.75%	1,353 $15,000
Q1 2024 May 10, 2024	BUY	$12.17 - $24.61 $2,008 - $4,060	165 Added 9.37%	1,926 $40,000
Q4 2023 Feb 09, 2024	BUY	$12.89 - $20.82 $9,615 - $15,531	746 Added 73.5%	1,761 $31,000
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $15,604 - $18,950	-948 Reduced 48.29%	1,015 $16,000
Q2 2023 Aug 11, 2023	BUY	$17.23 - $21.71 $17,212 - $21,688	999 Added 103.63%	1,963 $39,000
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $14,500 - $19,689	-802 Reduced 45.41%	964 $18,000
Q4 2022 Feb 10, 2023	SELL	$20.4 - $24.73 $1,652 - $2,003	-81 Reduced 4.39%	1,766 $40,000
Q3 2022 Nov 10, 2022	BUY	$22.29 - $35.04 $27,193 - $42,748	1,220 Added 194.58%	1,847 $48,000
Q2 2022 Aug 12, 2022	SELL	$19.35 - $35.04 $26,374 - $47,759	-1,363 Reduced 68.49%	627 $15,000
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $14,181 - $19,762	-576 Reduced 22.45%	1,990 $66,000
Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $27,563 - $36,775	913 Added 55.23%	2,566 $83,000
Q3 2021 Nov 05, 2021	SELL	$29.09 - $45.68 $23,388 - $36,726	-804 Reduced 32.72%	1,653 $69,000
Q2 2021 Aug 06, 2021	BUY	$32.46 - $40.48 $38,335 - $47,806	1,181 Added 92.55%	2,457 $95,000
Q1 2021 May 07, 2021	SELL	$33.61 - $49.95 $6,318 - $9,390	-188 Reduced 12.84%	1,276 $43,000
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $28,005 - $52,113	1,056 Added 258.82%	1,464 $66,000
Q3 2020 Nov 06, 2020	SELL	$27.01 - $40.26 $15,260 - $22,746	-565 Reduced 58.07%	408 $11,000
Q2 2020 Aug 07, 2020	SELL	$27.75 - $43.44 $7,104 - $11,120	-256 Reduced 20.83%	973 $35,000
Q1 2020 May 08, 2020	SELL	$21.5 - $54.2 $11,416 - $28,780	-531 Reduced 30.17%	1,229 $39,000
Q4 2019 Feb 07, 2020	BUY	$34.54 - $44.87 $38,201 - $49,626	1,106 Added 169.11%	1,760 $72,000
Q3 2019 Nov 08, 2019	SELL	$31.84 - $50.88 $19,167 - $30,629	-602 Reduced 47.93%	654 $23,000
Q2 2019 Aug 09, 2019	BUY	$42.0 - $59.29 $2,772 - $3,913	66 Added 5.55%	1,256 $0
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $41,309 - $63,199	1,012 Added 568.54%	1,190 $0
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $146,114 - $280,760	-3,736 Reduced 95.45%	178 $7,000
Q3 2018 Nov 09, 2018	SELL	$65.0 - $82.15 $190,905 - $241,274	-2,937 Reduced 42.87%	3,914 $0
Q2 2018 Aug 10, 2018	BUY	$27.2 - $74.35 $186,347 - $509,371	6,851 New	6,851 $0

Others Institutions Holding RGNX

# of Institutions

191

Shares Held

45.4M

Call Options Held

184K

Put Options Held

56.7K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $367M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Regenxbio Inc. Transaction History